News

Vator Securities advises Visiopharm on a DKK100 million private placement

24 August 2018

ATP, the Danish Growth Fund and the C. L. David Foundation and Collection are among the new investors. The increased capital commitment is an essential part of the company’s growth strategy within the field of tissue diagnostics- and research software for cancer.

Vator Securities Sole Bookrunner in Nanoform SEK 71 million private placement

5 July 2018

The private placement was directed to Swedish and Finnish, HNWI, family offices and institutional investors where Mandatum Life Insurance Company (Sampo Group) acted as anchor investor.

Vator Securities advises AlzeCure Pharma on SEK 40 million directed share issue

2 July 2018

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 40 million.

Sole Bookrunner in the largest ever direct share issue in a diagnostics company in Sweden

12 June 2018

Vator Securities Sole Bookrunner in successful SEK 324 million direct share issue in Immunovia, the largest ever in a diagnostics company in Sweden.

Vator Securities advises Plastics Unbound on SEK 50 million Private Placement

10 June 2018

Vator Securities acted as Financial Adviser in connection with the transaction raising SEK 50 million.

Vator Securities advises Ascelia Pharma on SEK 60 million Pre-IPO share issue

17 May 2018

Vator Securities acted as Financial Adviser in connection with the transaction raising SEK 60 million.

Dagens PS Appoints Homan Panahi Entrepreneur of the Week

2 February 2018

“Entrepreneur of the Week” highlights entrepreneurs, innovators and business leaders who shape Swedish commerce.

Vator Securities advises Immunovia in record breaking capital raise

20 October 2016

The capital raise of SEK 218.7 million, which was divided into a private placement share issue of SEK 189.9 million and a rights issue of SEK 28.7 million, broke the record for raising of capital for a diagnostics company on NASDAQ First North Stockholm.